Painless bronchoscopy treatment
Conditions
Interventions
Group B:Esketamine Injection
Group A:Propofol + remifentanil
Sponsors
People's Hospital of Honghuagang District, Zunyi City
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients who need painless ultra-thin bronchoscopy combined with EBUS-GS examination, aged 18 to 70 years, ASA I to III patients; those who have signed an informed consent form voluntarily.
Exclusion criteria
Exclusion criteria: Patients with major organ dysfunction; patients with malignant tumors; patients with severe respiratory diseases or other major diseases of the system; patients with allergies to the drugs in this study; patients with mental retardation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of severe cough;Average number of coughs; | — |
Secondary
| Measure | Time frame |
|---|---|
| signs of life;Propofol dosage;Time to loss of consciousness and time to recovery;The incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactHuang qin
People's Hospital of Honghuagang District, Zunyi City
Outcome results
None listed